Terms: = Liver cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
37 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.
Ding Z; Pan Y; Shang T; Jiang T; Lin Y; Yang C; Pang S; Cui X; Wang Y; Feng XF; Xu M; Pei M; Chen Y; Li X; Ding J; Tan Y; Wang H; Dong L; Wang L
Nat Commun; 2023 Oct; 14(1):6269. PubMed ID: 37805657
[TBL] [Abstract] [Full Text] [Related]
3. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10.
Qi J; Li J; Bie B; Shi M; Zhu M; Tian J; Zhu K; Sun J; Mu Y; Li Z; Guo Y
Phytother Res; 2023 Jan; 37(1):295-309. PubMed ID: 36070933
[TBL] [Abstract] [Full Text] [Related]
4. Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.
Liu P; Zhong Q; Song Y; Guo D; Ma D; Chen B; Lan J; Liu Q
Int J Biol Sci; 2022; 18(7):2932-2948. PubMed ID: 35541917
[TBL] [Abstract] [Full Text] [Related]
5. Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/mdm2-mediated P53 Inactivation.
Bian S; Ni W; Zhu M; Zhang X; Qiang Y; Zhang J; Ni Z; Shen Y; Qiu S; Song Q; Xiao M; Zheng W
Int J Biol Sci; 2022; 18(3):1022-1038. PubMed ID: 35173534
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract] [Full Text] [Related]
7. Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
Valenciaga A; Iwenofu OH; Tinoco G
J Natl Compr Canc Netw; 2021 Jul; 19(7):775-779. PubMed ID: 34340207
[TBL] [Abstract] [Full Text] [Related]
8. Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.
Wang K; Li L; Franch-Expósito S; Le X; Tang J; Li Q; Wu Q; Bassaganyas L; Camps J; Zhang X; Li H; Foukakis T; Xiang T; Wu J; Ren G
Mol Oncol; 2022 Jun; 16(12):2413-2431. PubMed ID: 34146382
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients.
Puetkasichonpasutha J; Namwat N; Sa-Ngiamwibool P; Titapun A; Suthiphongchai T
Asian Pac J Cancer Prev; 2020 Mar; 21(3):791-798. PubMed ID: 32212809
[TBL] [Abstract] [Full Text] [Related]
10. Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
Chen Y; Li H; Zhang W; Qi W; Lu C; Huang H; Yang Z; Liu B; Zhang L
Toxicol Appl Pharmacol; 2020 Jan; 387():114848. PubMed ID: 31809756
[TBL] [Abstract] [Full Text] [Related]
11. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells.
Riedel R; Pérez-Pérez A; Carmona-Fernández A; Jaime M; Casale R; Dueñas JL; Guadix P; Sánchez-Margalet V; Varone CL; Maymó JL
Sci Rep; 2019 Oct; 9(1):14193. PubMed ID: 31578445
[TBL] [Abstract] [Full Text] [Related]
12. mdm2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.
Wang W; Cheng JW; Qin JJ; Hu B; Li X; Nijampatnam B; Velu SE; Fan J; Yang XR; Zhang R
Cancer Lett; 2019 Sep; 459():156-167. PubMed ID: 31181320
[TBL] [Abstract] [Full Text] [Related]
13. mdm2 copy number increase: a poor prognostic, molecular event in esophageal squamous cell carcinoma.
Sawada R; Maehara R; Oshikiri T; Nakamura T; Itoh T; Kodama Y; Kakeji Y; Zen Y
Hum Pathol; 2019 Jul; 89():1-9. PubMed ID: 31004651
[TBL] [Abstract] [Full Text] [Related]
14. Troxerutin subdues hepatic tumorigenesis via disrupting the mdm2-p53 interaction.
Thomas NS; George K; Selvam AAA
Food Funct; 2018 Oct; 9(10):5336-5349. PubMed ID: 30259932
[TBL] [Abstract] [Full Text] [Related]
15. MYL6B, a myosin light chain, promotes mdm2-mediated p53 degradation and drives HCC development.
Xie X; Wang X; Liao W; Fei R; Wu N; Cong X; Chen Q; Wei L; Wang Y; Chen H
J Exp Clin Cancer Res; 2018 Feb; 37(1):28. PubMed ID: 29439719
[TBL] [Abstract] [Full Text] [Related]
16. MCUR1-Mediated Mitochondrial Calcium Signaling Facilitates Cell Survival of Hepatocellular Carcinoma via Reactive Oxygen Species-Dependent P53 Degradation.
Ren T; Wang J; Zhang H; Yuan P; Zhu J; Wu Y; Huang Q; Guo X; Zhang J; Ji L; Li J; Zhang H; Yang H; Xing J
Antioxid Redox Signal; 2018 Apr; 28(12):1120-1136. PubMed ID: 28938844
[TBL] [Abstract] [Full Text] [Related]
17. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.
Li Q; Liu X; Jin K; Lu M; Zhang C; Du X; Xing B
BMC Cancer; 2017 Aug; 17(1):605. PubMed ID: 28859621
[TBL] [Abstract] [Full Text] [Related]
18. Hepatitis B virus X protein promotes the stem-like properties of OV6
Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
[TBL] [Abstract] [Full Text] [Related]
19. Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan™) platform.
Qiao Z; Pan X; Parlayan C; Ojima H; Kondo T
Biochim Biophys Acta Proteins Proteom; 2017 Apr; 1865(4):434-443. PubMed ID: 27663888
[TBL] [Abstract] [Full Text] [Related]
20. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
Ye C; Tao R; Cao Q; Zhu D; Wang Y; Wang J; Lu J; Chen E; Li L
Int J Oncol; 2016 Aug; 49(2):589-602. PubMed ID: 27221337
[TBL] [Abstract] [Full Text] [Related]
[Next]
